|
Report No. : |
336913 |
|
Report Date : |
08.09.2015 |
IDENTIFICATION DETAILS
|
Name : |
SHOWA SEIYAKU CO LTD |
|
|
|
|
Registered Office : |
4-2 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2015 |
|
|
|
|
Date of Incorporation : |
April 1980 |
|
|
|
|
Com. Reg. No.: |
1803-01-005829 (Aichi-Toyohashi) |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki
Kaisha) |
|
|
|
|
Line of Business : |
Manufactures and processes crude drugs, kampo (Chinese drugs) products, health foods & teas, other (--100%) |
|
|
|
|
No. of Employees : |
22 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
COMPANY NAME
SHOWA SEIYAKU CO LTD
REGD NAME
Showa Seiyaku KK
MAIN OFFICE
4-2
Nishi-Hibarigaoka Tempakucho Toyohashi City Aichi-Pref 441-8122 JAPAN
Tel:
0532-38-0711 Fax: 0532-38-0700
*.. The is its factory
URL
E-Mail address: kaihatsu@showaseiyaku.co.jp
ACTIVITIES
Mfg,
processing of crude drugs, kampo products
BRANCHES
Nil
OVERSEAS
China,
Korea (--Business partners)
FACTORIES
Toyohashi
(as given)
OFFICERS
AKIRA
HAYASHI, PRES & CH
Tohru Shimizu,
rep dir
Toshiko
Hayashi, dir
Yen
Amount: In million Yen, unless
otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 420 M
PAYMENTSNO
COMPLAINTS CAPITAL Yen 44 M
TREND SLOW WORTH Yen 362 M
STARTED 1980 EMPLOYES 22
COMMENT
MFR OF CRUDE DRUGS.
FINANCIAL SITUATION CONSIDERED
FAIR AND GOOD FORORDINARY BUSINESS ENGAGEMENTS.
MAX
CREDIT LIMIT: ESTIMATED AT YEN 7.8 MILLION, ON 30 DAYS NORMAL TERMS.
HIGHLIGHTS
The subject company is a specialized mfr and processor of
crude drugs, kampo products, health foods & teas, other. Materials are imported. Clients include pharmaceutical mfrs, stores,
other, nationwide.
FINANCIAL INFORMATION
Financials are disclosed only partially.
The sales volume for Mar/2015 fiscal term amounted to Yen
420 million, an 11% down from Yen 470 million in the previous term. The net profit was posted at Yen 31 million,
compared with Yen 57 million a year ago.
For the current term ending Mar 2016 the net profit is
projected at Yen 35 million, on a 5% rise in turnover, to Yen 440 million.
The financial situation is considered FAIR and good for
ORDINARY business engagements. Max
credit limit is estimated at Yen 7.8 million, on 30 days normal terms.
REGISTRATION
Date Registered: Apr
1980
Regd No.: 1803-01-005829
(Aichi-Toyohashi)
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 352,000 shares
Issued:
88,000 shares
Sum: Yen
44 million
Major shareholders (%): Nagoya Small & Medium Business Investment &
Promotion Assn (50), Akira
Hayashi (29), Zentaro Shamoto (5), Toshio Kimata (5), Hatsuhiro Kamata 5),
other
No. of shareholders: 8
Nothing
detrimental is known as to the commercial morality of executives.
OPERATION
Activities: Manufactures and processes crude
drugs, kampo (Chinese drugs) products, health foods & teas, other (--100%)
Clients: [Mfrs, wholesalers] Paltec, All Japan
Drug, other to pharmaceutical mfrs, stores, other
No. of accounts: 350
Domestic areas of activities:
Nationwide
Suppliers: [Mfrs, wholesalers] PSSK Inc, CNP
Corp, other
Payment record: No
Complaints
Location:
Business area in Toyohashi. Office
premises at the caption address are owned and maintained satisfactorily.
Bank References:
Toyokawa Shinkin Bank
(Yayoi)
Aichi Bank (Toyohashi)
Relations: Satisfactory
FINANCES
(In Million Yen)
|
Terms Ending: |
|
31/03/2016 |
31/03/2015 |
31/03/2014 |
31/03/2013 |
|
Annual
Sales |
|
440 |
420 |
470 |
430 |
|
Recur.
Profit |
|
.. |
.. |
.. |
.. |
|
Net
Profit |
|
35 |
31 |
57 |
19 |
|
Total
Assets |
|
|
N/A |
N/A |
N/A |
|
Net
Worth |
|
|
362 |
331 |
274 |
|
Capital,
Paid-Up |
|
|
44 |
44 |
44 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
4.76 |
-10.64 |
9.30 |
10.26 |
|
Current Ratio |
|
|
.. |
.. |
.. |
|
N.Worth Ratio |
|
|
.. |
.. |
.. |
|
N.Profit/Sales |
|
7.95 |
7.38 |
12.13 |
4.42 |
Notes:
Financials are only partially disclosed.
Forecast
(or estimated) figures for the 31/03/2016 fiscal term.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.